Nombre del producto:1-(Oxetan-3-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

IUPAC Name:3-(oxetan-3-yl)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea

CAS:1260088-68-3
Fórmula molecular:C16H23BN2O4
Pureza:95%
Número de catálogo:CM136759
Peso molecular:318.18

Unidad de embalaje Stock disponible Precio($) Cantidad
CM136759-1g in stock ǕƻƻǕ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1260088-68-3
Fórmula molecular:C16H23BN2O4
Punto de fusión:-
Código de sonrisas:O=C(NC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)NC3COC3
Densidad:
Número de catálogo:CM136759
Peso molecular:318.18
Punto de ebullición:
Nº Mdl:MFCD22690835
Almacenamiento:

Category Infos

Oxetanes
Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.

Column Infos

Boronic Acids and Esters
Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).